ERBB2 and breast cancer: These frequencies of breast cancer subtypes are similar to the subtypes of DCISs and microinvasive carcinomas in our data, which had higher HER2-positive rates (HR-positive and -negative) than invasive breast carcinomas, which are usually approximately 15% [12].